Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: A Tuberculosis Network European Trialsgroup (TBnet) study.

Guglielmetti L, Tiberi S, Burman M, Kunst H, Wejse C, Togonidze T, Bothamley G, Lange C; TBNET.

Eur Respir J. 2018 Jun 7. pii: 1800537. doi: 10.1183/13993003.00537-2018. [Epub ahead of print] No abstract available.

PMID:
29880656
2.

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D; for NTM-NET.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available.

PMID:
29567726
3.

Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.

Guglielmetti L, Barkane L, Le Dû D, Marigot-Outtandy D, Robert J, Veziris N, Yazdanpanah Y, Kuksa L, Caumes E, Fréchet-Jachym M.

Eur Respir J. 2018 Mar 22;51(3). pii: 1702550. doi: 10.1183/13993003.02550-2017. Print 2018 Mar. No abstract available.

PMID:
29419439
4.

Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.

Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):54-59. doi: 10.5588/ijtld.17.0387.

PMID:
29297426
5.

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond.

D'Ambrosio L, Bothamley G, Caminero Luna JA, Duarte R, Guglielmetti L, Muñoz Torrico M, Payen MC, Saavedra Herrera N, Salazar Lezama MA, Skrahina A, Tadolini M, Tiberi S, Veziris N, Migliori GB.

Pulmonology. 2018 Mar - Apr;24(2):132-141. doi: 10.1016/j.rppnen.2017.10.005. Epub 2017 Dec 8.

6.

Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance.

Guglielmetti L, Varaine F, Huerga H, Bonnet M, Rich ML, Mitnick CD.

Eur Respir J. 2017 Jul 20;50(1). pii: 1700598. doi: 10.1183/13993003.00598-2017. Print 2017 Jul. No abstract available.

7.

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

Varaine F, Guglielmetti L, Mitnick CD.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1490-1491. doi: 10.1164/rccm.201705-0988LE. No abstract available.

PMID:
28715258
8.

Comparative evaluation of the results of three techniques in the reconstruction of the anterior cruciate ligament, with a minimum follow-up of two years.

Cury RPL, Sprey JWC, Bragatto ALL, Mansano MV, Moscovici HF, Guglielmetti LGB.

Rev Bras Ortop. 2017 May 10;52(3):319-324. doi: 10.1016/j.rboe.2017.05.003. eCollection 2017 May-Jun.

9.

Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity?

Guglielmetti L.

Eur Respir J. 2017 May 21;49(5). pii: 1700738. doi: 10.1183/13993003.00738-2017. Print 2017 May. No abstract available.

PMID:
28529206
10.

Aortic Valve Annular Sizing: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography.

George I, Guglielmetti LC, Bettinger N, Moss A, Wang C, Kheysin N, Hahn R, Kodali S, Leon M, Bapat V, Borger MA, Williams M, Smith C, Khalique OK.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e005968. doi: 10.1161/CIRCIMAGING.116.005968.

11.

Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed.

Burman M, Nikolayevskyy V, Kontsevaya I, Molina-Moya B, Rzhepishevska O, Guglielmetti L.

J Public Health (Oxf). 2018 Mar 1;40(1):210-211. doi: 10.1093/pubmed/fdx014. No abstract available.

PMID:
28334761
12.

Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.

Guglielmetti L, Hewison C, Avaliani Z, Hughes J, Kiria N, Lomtadze N, Ndjeka N, Setkina S, Shabangu A, Sikhondze W, Skrahina A, Veziris N, Furin J.

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):167-174. doi: 10.5588/ijtld.16.0493.

13.

The influence of femoral tunnel length on graft rupture after anterior cruciate ligament reconstruction.

Guglielmetti LGB, Shimba LG, do Santos LC, Severino FR, Severino NR, de Moraes Barros Fucs PM, de Paula Leite Cury R.

J Orthop Traumatol. 2017 Sep;18(3):243-250. doi: 10.1007/s10195-017-0448-9. Epub 2017 Feb 18.

14.

Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.

Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M; French MDR-TB Management Group.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601799. doi: 10.1183/13993003.01799-2016. Print 2017 Mar.

PMID:
28182570
15.

Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.

Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A; CNR MyRMA and the Tuberculosis Consilium of the CNR MyRMA; CNR MyRMA and Tuberculosis Consilium of the CNR MyRMA.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601719. doi: 10.1183/13993003.01719-2016. Print 2017 Mar. No abstract available.

PMID:
28182568
16.

Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.

Guglielmetti L, Le Dû D, Fréchet-Jachym M, Mitnick C.

Am J Respir Crit Care Med. 2016 Nov 1;194(9):1170-1171. No abstract available.

PMID:
27797614
17.

Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.

Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C.

Clin Microbiol Infect. 2017 Mar;23(3):131-140. doi: 10.1016/j.cmi.2016.10.008. Epub 2016 Oct 15. Review.

18.

Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.

Varaine F, Guglielmetti L, Huerga H, Bonnet M, Kiria N, Sitienei JK, Rich M, Mitnick CD.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1028-1029. No abstract available.

PMID:
27739887
19.

Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.

Bothamley GH, Ehlers C, Salonka I, Skrahina A, Orcau A, Codecasa LR, Ferrarese M, Pesut D, Solovic I, Dudnyk A, Anibarro L, Denkinger C, Guglielmetti L, Muylle I, Confalonieri M.

BMC Pregnancy Childbirth. 2016 Oct 12;16(1):304.

20.

Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.

Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E.

Expert Rev Anti Infect Ther. 2016 Dec;14(12):1139-1154. Epub 2016 Oct 3. Review.

PMID:
27690688
21.

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.

Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration *.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. No abstract available.

PMID:
27685538
22.

Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?

Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort.

Eur Respir J. 2016 Aug;48(2):582-5. doi: 10.1183/13993003.00411-2016. Epub 2016 Jun 23. No abstract available.

23.

The Use of Hypothermic Circulatory Arrest During Heart Transplantation Does Not Worsen Posttransplant Survival.

Sorabella RA, Guglielmetti L, Bader A, Gomez A, Takeda K, Chai PJ, Takayama H, Bacha EA, Naka Y, George I.

Ann Thorac Surg. 2016 Oct;102(4):1260-5. doi: 10.1016/j.athoracsur.2016.03.058. Epub 2016 May 19.

24.

Bridging Anticoagulation After Mechanical Aortic Heart Valve Replacement: A Questionable Routine.

Guglielmetti LC, Sorabella R, Chiuzan C, Najjar M, Castillero E, Lambert D, Kim MJ, Kurlansky P, Borger MA, Argenziano M, Smith CR, George I.

Ann Thorac Surg. 2016 Jul;102(1):48-54. doi: 10.1016/j.athoracsur.2016.01.030. Epub 2016 Apr 9.

PMID:
27068176
25.

Bicuspid aortic valve increases risk of permanent pacemaker implant following aortic root replacement.

Guglielmetti L, Nazif T, Sorabella R, Akkoc D, Kantor A, Gomez A, Wang C, Takayama H, Dizon J, Borger M, George I.

Eur J Cardiothorac Surg. 2016 Sep;50(3):497-503. doi: 10.1093/ejcts/ezw044. Epub 2016 Mar 2.

PMID:
26941247
26.

Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.

Sorabella RA, Guglielmetti L, Kantor A, Castillero E, Takayama H, Schulze PC, Mancini D, Naka Y, George I.

Transplant Proc. 2015 Dec;47(10):2944-51. doi: 10.1016/j.transproceed.2015.10.021.

27.

Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.

Guglielmetti L, Mougari F, Lopes A, Raskine L, Cambau E.

Future Microbiol. 2015;10(9):1467-83. doi: 10.2217/fmb.15.64. Epub 2015 Sep 7. Review.

PMID:
26344005
28.

Total knee arthroplasty with mobile tibial weight-bearing: clinical evaluation after a minimum of five years of postoperative follow-up.

Guglielmetti LG, da Costa PP, de Paula Leite Cury R, de Oliveira VM, Severino NR, de Camargo OP.

Rev Bras Ortop. 2015 May 30;50(3):290-4. doi: 10.1016/j.rboe.2015.05.004. eCollection 2015 May-Jun.

29.

Reversibility of chronic kidney disease and outcomes following aortic valve replacement†.

Najjar M, Yerebakan H, Sorabella RA, Guglielmetti L, Vandenberge J, Kurlansky P, Williams MR, Argenziano M, Smith CR, George I.

Interact Cardiovasc Thorac Surg. 2015 Oct;21(4):499-505. doi: 10.1093/icvts/ivv196. Epub 2015 Jul 14.

PMID:
26180091
30.

Anterior cruciate ligament reconstruction: a new cortical suspension device for femoral fixation with transtibial and transportal techniques.

Guglielmetti LG, Cury Rde P, de Oliveira VM, de Camargo OP, Severino NR, Fucs PM.

J Orthop Surg Res. 2014 Nov 19;9:110. doi: 10.1186/s13018-014-0110-7.

31.

False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.

de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Dominguez J, Eyuboglu F, Ghanem M, Goletti D, Dilektasli AG, Guglielmetti L, Koh WJ, Latorre I, Losi M, Polanova M, Ravn P, Ringshausen FC, Rumetshofer R, de Souza-Galvão ML, Thijsen S, Bothamley G, Bossink A; TBNET.

Eur Respir J. 2015 Jan;45(1):279-83. doi: 10.1183/09031936.00120214. Epub 2014 Oct 30. No abstract available.

32.

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort.

Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15.

PMID:
25320286
33.

Rebound in QuantiFERON-TB Gold In-Tube response after active tuberculosis treatment.

Guglielmetti L, Mazzaferri F, Cordioli M, Conti M, Lo Cascio G, Concia E, Cazzadori A.

J Infect. 2015 Jan;70(1):96-8. doi: 10.1016/j.jinf.2014.07.007. Epub 2014 Jul 26. No abstract available.

PMID:
25068223
34.

[Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis].

Tedesco A, Guglielmetti L, Conti M, Cazzadori A, Concia E.

Infez Med. 2013 Jun;21(2):146-8. Italian.

35.

Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay.

Guglielmetti L, Cazzadori A, Conti M, Boccafoglio F, Vella A, Ortolani R, Concia E.

Int J Tuberc Lung Dis. 2013 Jun;17(6):825-8. doi: 10.5588/ijtld.12.0361.

PMID:
23676170
36.

Isoniazid preventive therapy in human immunodeficiency virus infection.

Guglielmetti L, Lattuada E, Lanzafame M, Vento S.

Int J Tuberc Lung Dis. 2012 Apr;16(4):567-8. doi: 10.5588/ijtld.11.0844. No abstract available.

PMID:
22640519
37.
38.

Tuberculosis incidence at the Burundi-Rwanda border 15 years after the civil war.

Guglielmetti L, Cazzadori A, Scardigli A, Valentinotti R, Conti M, Concia E.

Clin Infect Dis. 2012 Jan 1;54(1):155-6. doi: 10.1093/cid/cir779. Epub 2011 Nov 3. No abstract available.

PMID:
22052891
39.

[Herpes zoster in general medicine: experience of the Italian group Netaudit].

Del Zotti F, Guglielmetti L, Conti M, Valentinotti R, Cazzadori A, Concia E.

Infez Med. 2011 Jun;19(2):106-12. Italian.

40.

RESULTS OF ADDUCTORS MUSCLE TENOTOMY IN SPASTIC CEREBRAL PALSY.

Guglielmetti LG, Santos RM, Mendonça RG, Yamada HH, Assumpçao RM, Fucs PM.

Rev Bras Ortop. 2015 Nov 17;45(4):420-5. doi: 10.1016/S2255-4971(15)30391-8. eCollection 2010 Jul-Aug.

41.

Adrenal crisis during anti-tuberculosis treatment.

Guglielmetti L, Conti M, Grigolo C, Cazzadori A, Concia E.

Int J Tuberc Lung Dis. 2010 Jul;14(7):929-30. No abstract available.

PMID:
20550784
42.

Photochemical and biological degradation of water-soluble FWAs.

Guglielmetti L.

Environ Qual Saf Suppl. 1975;4:180-90.

PMID:
6265

Supplemental Content

Loading ...
Support Center